http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109912570-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3adbf5f940d3e0e19c55b7ab783c2a06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c75a44c7fa2b709df754857e2baf53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627d125efaa12d8e4ec909615847242a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75bf591f9a19a4d4fdee02790c03224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04121cd00260bddce20379ae64c3680
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da58bd691ca5804d3e6f688c2adc51d3
publicationDate 2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109912570-A
titleOfInvention A kind of preparation method of argatroban intermediate amidate
abstract The present invention relates to a kind of preparation method of argatroban intermediate amidate. , 4R)-4-methyl-2-piperidine formate, 3-methyl-8-quinoline sulfonyl chloride are substrate preparation (2R, 4R)-1-[N G -nitro-N 2- (3-methyl-8-quinolinesulfonyl)-L-arginyl]-4-methyl-2-piperidinecarboxylate ethyl ester. The beneficial effects of the invention are as follows: the production process eliminates the harsh conditions of water, avoids the occurrence of zero batch numbers, and the reaction is simplified into a one-step reaction operation, the post-processing process is simple and easy to operate, the solvent is easy to recycle, and the reduction of temperature makes the reaction The process is mild, the HPLC purity is increased by 14%, and the yield is increased by 13%, which is more realized by industrialization.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111961114-A
priorityDate 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105837658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0008746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105175490-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0823430-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414884152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15697772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415791865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10313307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421385604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46780287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411245646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450448281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426157752

Total number of triples: 44.